Ventura is bullish on Arvind Remedies and has recommended buy rating on the stock with a target of Rs 100 in its October 16, 2014 research report.
Sunidhi Securities is bullish on Arvind Remedies and has recommended buy rating on the stock with a target of Rs 66 in its October 9, 2014 research report.